Labs / Assays & in vitro testing
Quanterix
Billerica, MA, United States · quanterix.com
CLIA
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Quanterix provides biomarker detection, spatial biology, and tissue and liquid biomarker research services for research, translational, and clinical applications. It also offers Simoa assay and instrument products, spatial biology software, and LDT-related offerings. The company serves customers working in areas such as neurology, oncology, immunology, cardiology, and infectious disease.
They take quote requests by email.
What they offer
Accelerator Laboratory
Provides liquid and tissue biomarker research services.
Quanterix Spatial Accelerator
Provides CLIA-certified tissue biomarker services for spatial proteomic biomarker discovery, translational research, and clinical research needs, including a dedicated image analysis team.
Quanterix Simoa Accelerator
Listed as an Accelerator Laboratory service offering related to Simoa-based biomarker work.
phenoptr and phenoptrReports
Software tools for spatial relationships analysis and reporting.
inForm
Automated tissue analysis software for multimarker studies.
Phenochart
Software for visualizing and annotating spatial images.
Explore Simoa Assays and Reagents
Provides Simoa assay kits and reagents for ultrasensitive biomarker measurement.
Custom Assay Development
Custom assay development offering for Simoa technology.
Simoa LDT Assays
Listed laboratory-developed test assays including Simoa NfL LDT and LucentAD p-Tau 217.
What they work on
- Modalities
- Antibody, ADC
- Species and models
- human, mouse
- Assays and studies
- biomarker detection, spatial proteomic biomarker services, tissue biomarker services, automated tissue analysis, image analysis
- Instruments and platforms
- PhenoImager HT 2.0, Akoya PhenoCycler-Fusion 2.0, Akoya PhenoImager Fusion, HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System
- Therapeutic areas
- Neurology, Neuroinflammation, Pathology, Multiple Sclerosis, Traumatic Brain Injury, Oncology, Immunology, Cardiology, Infectious Disease, COVID-19
- Quality
- CLIA-certified (tissue biomarker services)
- Address
- 2026 Quanterix Names Dr. Yuri Fesko Chief Medical Officer SEP 14, 2026 Quanterix Names Dr. Yu
Public records
- CLIA
- 22D1053083
- CMS CLIA laboratory
- 22D1053083 · BEDFORD source
Similar labs. Sparx BIO, Veloxity Labs, 3C Therapeutics, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from quanterix.com. Work here? Claim this listing.